GlassScriptPhysician profile
Sara Jane Wasilenko
NPI 1528387941
$6,600.29
in general payments reported to CMS, 2019-2025
13 companies · $862 in 2025
The $862 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.78 · 2020: $50.29 · 2021: $183 · 2022: $170 · 2023: $4,999 · 2024: $270 · 2025: $862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,775 · Food and Beverage: $2,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,775.06 |
| Food and Beverage | $2,356.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $3,666.32 | 2020-2025 | Gore Tag Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Penumbra, INC. | $1,862.87 | 2023-2024 | Indigo System, Penumbra Coil 400 |
| Medtronic, INC. | $309.58 | 2021-2023 | Endurant Iis, Onyx Frontier |
| Cook Medical LLC | $305.51 | 2021-2024 | Zilver Ptx |
| Abiomed | $116.77 | 2023 | Impella |
| Amgen INC. | $97.51 | 2023 | Repatha |
| Silk Road Medical, INC. | $67.67 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Medtronic Vascular, INC. | $52.96 | 2019-2020 | |
| Lemaitre Vascular, INC. | $39.56 | 2019-2021 | |
| Boston Scientific Corporation | $36.95 | 2021-2024 | |
| Smith+Nephew, INC. | $18.78 | 2020 | |
| Philips North America LLC | $12.98 | 2019 | |
| Inari Medical, INC. | $12.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Wasilenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.